The Reproductive Infectious Diseases Program is a network of health professionals, researchers and knowledge users dedicated to advancing reproductive infectious diseases care and research internationally. Through local, national and global research collaborations, the team works to address emergent knowledge gaps and provide evidence-based guidance for the prevention, treatment, and care of reproductive infectious diseases.

  • Reproductive Infectious Diseases Research Program Annual Report

    Our Annual Report is here! Read about the work that the RID team has been involved in over the past year. January 15th, 2023 Read More

  • RID COVID-19 Research Projects Timeline

    A timeline of our 3 COVID-19 research projects, highlighting the RID team’s hard work from March 2020 to December 2022! Read More

  • COVERED: COVID-19 Vaccine Registry for Pregnant and Lactating Individuals

    If you are pregnant or lactating, we are looking to hear your opinions on COVID-19 vaccinations, particularly the fall booster. Recruitment is currently underway across Canada for the COVERED Vaccine Registry. Go to covered.med.ubc.ca for more information and to participate. Read More

  • UBC Q & A with Dr. Money

    With bivalent COVID-19 boosters rolling out across Canada, Dr. Deborah Money answers questions about what people who are pregnant need to know. Read More

  • New publication alert!

    Congratulations to Drs Elisabeth McClymont and Deborah Money for their newest publication in the University of British Columbia Medical Journal, titled “Addressing the needs of pregnant individuals during the COVID-19 pandemic”. October 18th, 2022. Read More

  • Interim Guidance on Monkeypox Exposure for Pregnant People

    Drs. Vanessa Poliquin, Andrea Atkinson, Isabelle Boucoiran, Chelsea Elwood, Julie van Schalkwyk, Mark H. Yudin, and Deborah Money released these guidelines on behalf of the SOGC’s Infectious Diseases Committee. June 9th, 2022. Read More

  • CIHR Spring Project Funding

    Congratulations to Dr. Money and the NOVA-HIV Study Team, who have been successful in receiving funding for their project titled “A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV”. July 15th, 2022 Read More

  • CITF News Release

    Data from our Canadian Antenatal Serosurveillance Study are highlighted in the most recent news release from Canada’s COVID-19 Immunity Task Force (CITF). July 6th, 2022 Read More

  • New publication alert!

    Congratulations to Drs. Elisabeth McClymont, Arianne Albert and Deborah Money, along with the CTN 236 HPV in HIV Study Team, for their recent publication in the International Journal of STD & AIDS.  Read More

  • New publication alert!

    A new publication, titled “Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods” has been published in PloS ONE. June 16th, 2022 Read More

Highlighted Research

NOVA-HIV

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV

The goal of this study is to explore reduced dosing of the nonavalent HPV vaccine in women living with HIV. This multi-site phase IV clinical trial will carry on from our previous HPV in HIV studies. Investigators intend to begin recruiting for the NOVA-HIV study within the first half of 2023.

Antenatal Serostudies

Canadian Population Serological Survey Utilizing Antenatal Serum Samples

This national project will improve our understanding of the seroprevalence of antibodies to SARS-CoV-2 using antenatal blood samples which are routinely taken as part of prenatal care. Pregnant women are representative of generally healthy adults from ages 18-45 years from all socioeconomic and cultural backgrounds; use of these existing samples will provide a window into the generally healthy adult population of Canada as a whole.

COVERED Vaccine Registry

Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals (COVERED)

The goal of this program is to monitor the attitudes, safety and effectiveness of the various vaccines for those who are pregnant and lactating. Through this survey, we will document vaccine safety for those who are pregnant and lactating. This project is endorsed by COVID-19 Immunity Task Force and funded by Public Health Agency of Canada.